Inventor · disambiguated record
Markus Henrich
Also filed as: HENRICH MARKUS
10 granted patents·10 pending applications·25 citations·filing 2002–2021
84Inventor score
Top patents by PatentIndex Score
20 records- 0180US7985753B2Substituted pyrazolo[1,5-A]pyrimidines as metabotropic glutamate receptor modulatorsMERZ PHARMA GMBH & CO KGAA·Filed 2007·Granted Jul 26, 2011·6 cites·19 claims
- 0278US6828462B2Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonistsMERZ PHARMA GMBH & CO KGAA·Filed 2002·Granted Dec 7, 2004·14 cites·9 claims
- 0375US11891455B2Polymorph form of (r)-2-[2-amino-3-(indol-3-yl)propionylamino]-2- methylpropionic acid and uses thereofGALIMEDIX THERAPEUTICS INC·Filed 2020·Granted Feb 6, 2024·1 cites·14 claims
- 0469US7947689B2Substituted pyrazolo[1,5-a]pyrimidines as metabotropic glutamate receptor modulatorsMERZ PHARMA GMBH & CO KGAA·Filed 2007·Granted May 24, 2011·1 cites·19 claims
- 0567US7598384B2Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptorsMERZ PHARMA GMBH & CO KGAA·Filed 2005·Granted Oct 6, 2009·1 cites·77 claims
- 0662US7022729B2Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonistsMERZ PHARMA GMBH & CO KGAA·Filed 2003·Granted Apr 4, 2006·1 cites·3 claims
- 0761US2009227582A1Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptorsMERZ PHARMA GMBH & CO KGAA·Filed 2009·Application pending·0 cites
- 0857US8288549B2Glycine B antagonistHENRICH MARKUS·Filed 2009·Granted Oct 16, 2012·1 cites·12 claims
- 0956US2007185151A1Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonistsMERZ PHARMA GMBH & CO KGAA·Filed 2007·Application pending·0 cites
- 1055US7238703B2Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonistsMERZ PHARMA GMBH & CO KGAA·Filed 2005·Granted Jul 3, 2007·0 cites·3 claims
- 1153US7550482B2Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptorsMERZ PHARMA GMBH & CO KGAA·Filed 2005·Granted Jun 23, 2009·0 cites·11 claims
- 1248US2011003820A1Pyrazolopyrimidines, a process for their preparation and their use as medicineMERZ PHARMA GMBH & CO KGAA·Filed 2009·Application pending·0 cites
- 1347US2011212956A1Pyrazolopyrimidines for treating CNS disordersMERZ PHARMA GMBH & CO KGAA·Filed 2011·Application pending·0 cites
- 1445US2023242483A1Crystalline forms of solvates of tryptophan derivatives, compositions comprising them and uses thereofGALIMEDIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1545US2007299113A1Metabotropic glutamate receptor modulatorsMERZ PHARMA GMBH & CO KGAA·Filed 2007·Application pending·0 cites
- 1642US2006004001A1Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptorsMERZ PHARMA GMBH & CO KGAA·Filed 2005·Application pending·0 cites
- 1738US2006074083A1Cyclic and acyclic propenones for treating CNS disordersMERZ PHARMA GMBH & CO KGAA·Filed 2005·Application pending·0 cites
- 1827US2012178742A1Metabotropic glutamate receptor modulatorsHENRICH MARKUS·Filed 2010·Application pending·0 cites
- 1924US2012220577A1Glycine b antagonistsHENRICH MARKUS·Filed 2010·Application pending·0 cites
- 2022US8784847B2Synthesis of 1-amino-1,3,3,5,5,-cyclohexane mesylateHENRICH MARKUS·Filed 2010·Granted Jul 22, 2014·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when Markus Henrich files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →